FoundationOne CDx

FoundationOne CDx is a comprehensive genomic test that analyzes the DNA of a tumor to identify mutations and changes that may contribute to cancer. By examining over 300 genes, it helps doctors understand the specific characteristics of a patient's cancer, guiding personalized treatment options. This test can identify potential targeted therapies, immunotherapies, or clinical trials that might be more effective for the individual, ultimately improving treatment outcomes. FoundationOne CDx is FDA-approved and is often used to tailor cancer treatments based on the unique genetic profile of a patient's tumor.